Andrew Saxon, MD
Personal Statement
My area of expertise is addiction psychiatry.
Department Affiliations
Centers/Programs
Training Programs
Scholarly Expertise
Teaching Philosophy
My training philosophy involves serving as a role model for my trainees as well as generally apply a supportive, Socratic method.
- NIDA Clinical Trials Network: Pacific Northwest Node
- Improving the implementation of smartphone-based contingency management in medical settings for the treatment of methamphetamine use disorder: a qualitative analysis of patient and clinician experiences
- Improving opioid use disorder treatment using contingency management via mHealth
- Impact of medical and recreational marijuana laws on cannabis, opioids and psychiatric medications: national study of VA patients, 2000 – 2024
- Preventing addiction related suicide
- Evaluating the Stepped Care for Opioid Use Disorder Train-the-Trainer (SCOUTT) Program
- Collaborating to Heal Addiction and Mental Health in Primary Care (CHAMP)
Recent Publications
Differences in buprenorphine initiation and retention for opioid use disorder between primary care and substance use disorder specialty care settings.
(2026 Jan 16)
J Subst Use Addict Treat 183(): 209895
Livingston NR, Malte CA, Frost MC, Saxon AJ, Gordon AJ, Hagedorn HJ, Kennedy AJ, Williams EC, Hawkins EJ
(2026 Jan 16)
J Subst Use Addict Treat 183(): 209895
Livingston NR, Malte CA, Frost MC, Saxon AJ, Gordon AJ, Hagedorn HJ, Kennedy AJ, Williams EC, Hawkins EJ
Quality of life and treatment effectiveness direct and indirect effects on cocaine abstinence outcomes during cocaine use disorder treatment.
(2026 Jan 1)
Drug Alcohol Depend 278(): 112993
Smith CL, McPherson SM, Rodin N, Hovland SE, Akana N, Miguel AQ, Marsden J, Saxon AJ
(2026 Jan 1)
Drug Alcohol Depend 278(): 112993
Smith CL, McPherson SM, Rodin N, Hovland SE, Akana N, Miguel AQ, Marsden J, Saxon AJ
Decline in offspring quantity but not quality from successive matings in male rainforest Drosophila, with no evidence for genetic divergence in male mating behaviour along elevational and density gradients.
(2026 Jan 8)
J Evol Biol 39(1): 26-38
Saxon AD, O'Brien EK, Jones NE, Bridle J
(2026 Jan 8)
J Evol Biol 39(1): 26-38
Saxon AD, O'Brien EK, Jones NE, Bridle J
Cannabis Legalization and Cannabis Use Disorder by Sex in Veterans Health Administration Patients, 2005-2019.
(2026)
Subst Use Misuse 61(2): 296-306
Wisell CG, Hasin DS, Wall MM, Alschuler D, Malte C, McDowell Y, Olfson M, Keyes KM, Cerdá M, Maynard CC, Keyhani S, Martins SS, Mannes ZL, Livne O, Fink DS, Bujno JM, Stohl M, Saxon AJ, Simpson TL
(2026)
Subst Use Misuse 61(2): 296-306
Wisell CG, Hasin DS, Wall MM, Alschuler D, Malte C, McDowell Y, Olfson M, Keyes KM, Cerdá M, Maynard CC, Keyhani S, Martins SS, Mannes ZL, Livne O, Fink DS, Bujno JM, Stohl M, Saxon AJ, Simpson TL
Factors associated with mortality following hospitalization among veterans with opioid use disorder.
(2025 Aug 25)
J Subst Use Addict Treat
Incze MA, Huebler S, Baylis JD, Stofko A, Kelley AT, Binswanger IA, Bart G, Saxon AJ, Manhapra A, Gordon AJ
(2025 Aug 25)
J Subst Use Addict Treat
Incze MA, Huebler S, Baylis JD, Stofko A, Kelley AT, Binswanger IA, Bart G, Saxon AJ, Manhapra A, Gordon AJ
Show complete publication list »
